Vancouver, British Columbia–(Newsfile Corp. – January 12, 2022) – CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company"), one of North America's leading functional beverage companies, today announced that iconic Sonoma County retailer Oliver's Market now carries CENTR's sparkling, low calorie CBD beverages, including both CENTR and CENTR Sugar Free.
Established in 1988, Oliver's Market is an employee-owned, independent gourmet grocer serving Sonoma County with four locations. They offer customers the finest selection of natural, conventional, and specialty products, with a commitment to support the community through hundreds of local partners, including farmers and producers of food, beverage, and wellness products. It has been named "Best Grocery Store" by North Bay Bohemian readers annually since 2000.
Today's announcement further reinforces CENTR's market position as the most widely distributed, retailer-focused CBD beverage in the United States.
"We are excited by the continued growth at retail locations with a focus on community, health and wellness. CENTR understands that consumers are shifting toward healthier, low sugar, low calorie beverages like CENTR and supports the mission of these retailers," said Company CFO David Young. "Our ability to meet consumer preferences in this market has explosive potential over the coming year," Young added.
"Oliver's is totally focused on delivering gourmet-quality products for the "Healthiest You" in Sonoma. CENTR's deep connectivity in Northern California makes us a natural partner to sell CENTR and CENTR Sugar Free," said Stacey Rivas, the Company's National Accounts Manager.
About CENTR Brands Corp. CENTR Brands Corp. is one of North America's leading functional beverage companies. CENTR develops and markets non-alcoholic, functional ingestibles for the global market. The Company produces CENTR and CENTR Sugar Free, both sparkling, low calorie, CBD beverages as well as CENTR Instant, a family of on-the-go CBD powders. For more information visit www.findyourcentr.com, and follow on Instagram at @findyourcentr.
For further information, contact media@findyourcentr.com.
On behalf of the Board,
CENTR BRANDS CORP.
/s/ Joseph Meehan
Joseph Meehan, Chief Executive Officer
This press release may contain "Forward-Looking Statements" within the meaning of applicable Canadian securities laws. Actual results may differ from those indicated as a result of finalization of the Company's financial statements as well as other risks and uncertainties. Such statements represent the Company's current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements and information other than as required by applicable laws, rules and regulations.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/109813
It's Wednesday morning, and Alibaba Group Holding (NYSE: BABA) stock is still going up. Do you remember what I said about Alibaba yesterday? Well, this morning, the chorus singing Alibaba's praises got even bigger.
BioMarin CEO JJ Bienaimé joins Yahoo Finance Live’s Julie Hyman and Anjalee Khemlani to discuss the company's first gene therapy product targeted to patients dealing with hemophilia, the future of biotechnology, biotech stocks, and key takeaways from JPMorgan’s annual health care conference.
Cathie Wood, the star fund manager and chief executive of ARK Invest, in a Tuesday monthly market update says that the used car market is where she is expecting possible losses after a surge in values.
MarketWatch Picks has highlighted these products and services because we think readers will find them useful; the MarketWatch News staff is not involved in creating this content. Consumer prices rose 7% in December, as compared to the same month in 2020, according to data from the Labor Department released in January. Now, U.S. inflation is at a nearly 40-year-high.
With the stock market still trading around record levels and interest rates exceptionally low, finding yield in the current market is tough. Right now, some of the highest-yielding stocks are in the mortgage real estate investment trust (REIT) space; however, that sector is risky given that the Fed is going to raise interest rates and vastly reduce its purchases of mortgage-backed securities. Here are some REITs that have a decent yield and are either highly safe or will benefit from the current rise in commodities and real estate.
If you're looking for some worthwhile growth stocks to buy and hold through the storm, you've come to the right place. Lithium Americas (NYSE: LAC), ChargePoint Holdings (NYSE: CHPT), and Cognex Corporation (NASDAQ: CGNX) are three growth stocks that could be good buys in January. Scott Levine (Lithium Americas): If you're like most growth investors, you've undoubtedly come across plenty of ink spilled about electric vehicles since the market is expected to grow considerably over the next decade.
The stock of QuantumScape (NYSE: QS) crashed 23% in December, according to data provided by S&P Global Market Intelligence. QuantumScape stock is already down another 10.9% this month, as of the time of this writing. The passage of President Joe Biden's $1.2 trillion infrastructure bill that earmarked $7.5 billion on building an EV charging network of 500,000 chargers sent EV stocks surging in November.
Several top U.S. oil stocks are in buy range Wednesday as oil prices rise amid OPEC+ production disruptions.
Tilray, Inc.'s(NASDAQ: TLRY)story of 2021 has been the one of boom and bust (once again), as the stock repeated the performance from 2018 – albeit on a much smaller scale. Although the stock gained on earnings results, digging deeper shows things are not what they seem.
Shares of Kinder Morgan (NYSE: KMI) have quietly gained 9% year to date as the energy sector continues to outperform the broader market. The largest natural gas pipeline infrastructure company in the U.S. is expected to report its fourth-quarter and full-year 2021 results in about a week. Let's dive into Kinder Morgan's business and its 6.3% dividend yield to see what makes it a top dividend stock for 2022.
The U.S.-listed shares of Koninklijke Philips N.V. plunged 15.7% toward a near two-year low in morning trading Wednesday, after the Netherlands-based medical technologies and products company provided a downbeat revenue outlook, citing "intensified global supply chain shortages" and the postponement of customer equipment installations. The stock, which was the biggest decliner listed on the NYSE, was headed for the biggest one-day selloff since it dropped 15.9% on Oct. 15, 2008. The stock is als
Here’s one to be aware of for 2022: Value stocks will most likely beat their growth counterparts. * The Vanguard S&P 500 Growth Index exchange traded fund (VOOG) is down 5.6% year to date, while the Vanguard S&P 500 Value Index fund (VOOV) is flat. * Value groups including banks and energy stocks are crushing growth stocks like Ark Invest’s favorite names.
In this article, we discuss 10 biotech stocks to buy according to Chinese billionaire Lei Zhang. If you want to skip our detailed analysis of these stocks, go directly to 5 Biotech Stocks To Buy According To Chinese Billionaire Lei Zhang. Hillhouse Capital Management was founded by Chinese billionaire investor and hedge fund manager Lei […]DISH Network (DISH) stock opened 3% higher on Wednesday amid a report that the satellite tv company is in talks with competitor DirecTV.
Shares of mobile game publisher Zynga (NASDAQ: ZNGA) are soaring on news of a buyout offer from fellow video game company Take-Two Interactive Software (NASDAQ: TTWO). Games formatted for a mobile device have emerged as the biggest revenue generator for the massive and still-growing video game market, which is homing in on $200 billion a year globally. As a result, other publishers have scooped up leading mobile game developers (like Electronic Arts' (NASDAQ: EA) takeover of Glu Mobile last summer), and now it's Take-Two's turn.
St. James Investment Company, an investment management firm, published its fourth-quarter 2021 investor letter – a copy of which can be downloaded here. In its fourth-quarter letter, the fund talked about the FAAMG stocks, the economic downturns and highlighted the market’s subsequent recovery, and included other significant events during the previous quarter. Spare some time […]Shares of the blank check company Digital World Acquisition Corp (NASDAQ: DWAC) rose 14% today for no apparent reason. As a special purpose acquisition company (SPAC), Digital World Acquisition Corp went public with the intent of acquiring a private business to bring it public. In late October, the SPAC announced that it intended to merge with and take public Trump Media & Technology Group, the parent of TRUTH Social.
Shares of the movie theater have fallen 16% though just six trading days in 2022. It doesn't have to end badly for AMC.
In this article, we will share with you the list of the top 22 packaging companies in USA. You can skip our detailed analysis of the USA’s packaging industry, and go directly to the Top 5 Packaging Companies in USA. The packaging industry has seen massive growth following a shift in consumer behavior around the […]Shares of PayPal Holdings Inc. are off 1.4% in Wednesday morning trading after Jefferies analyst Trevor Williams cut his rating on the stock to hold from buy, warning that the company faces a "muted" setup for the year ahead.